708 related articles for article (PubMed ID: 11257133)
41. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice.
Ochi M; Ohdan H; Mitsuta H; Onoe T; Tokita D; Hara H; Ishiyama K; Zhou W; Tanaka Y; Asahara T
Hepatology; 2004 May; 39(5):1321-31. PubMed ID: 15122761
[TBL] [Abstract][Full Text] [Related]
42. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
[TBL] [Abstract][Full Text] [Related]
43. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
Jiang W; Zhang C; Tian Z; Zhang J
Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
[TBL] [Abstract][Full Text] [Related]
44. The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells.
Feng X; Yan J; Wang Y; Zierath JR; Nordenskjöld M; Henter JI; Fadeel B; Zheng C
Mol Immunol; 2010 Aug; 47(14):2388-96. PubMed ID: 20542572
[TBL] [Abstract][Full Text] [Related]
45. In vivo hydrodynamic delivery of cDNA encoding IL-2: rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells.
Ortaldo JR; Winkler-Pickett RT; Bere EW; Watanabe M; Murphy WJ; Wiltrout RH
J Immunol; 2005 Jul; 175(2):693-9. PubMed ID: 16002664
[TBL] [Abstract][Full Text] [Related]
46. Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver.
Subleski JJ; Hall VL; Back TC; Ortaldo JR; Wiltrout RH
Cancer Res; 2006 Nov; 66(22):11005-12. PubMed ID: 17108139
[TBL] [Abstract][Full Text] [Related]
47. Gene transfer of the CD40-ligand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells.
Tomihara K; Kato K; Masuta Y; Nakamura K; Tanaka T; Hiratsuka H; Hamada H
Int J Cancer; 2007 Apr; 120(7):1491-8. PubMed ID: 17205529
[TBL] [Abstract][Full Text] [Related]
48. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
Kim HR; Park HJ; Park JH; Kim SJ; Kim K; Kim J
Cancer Immunol Immunother; 2004 May; 53(5):461-70. PubMed ID: 14648068
[TBL] [Abstract][Full Text] [Related]
49. α-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3.
Huang JR; Tsai YC; Chang YJ; Wu JC; Hung JT; Lin KH; Wong CH; Yu AL
J Immunol; 2014 Feb; 192(4):1972-81. PubMed ID: 24465013
[TBL] [Abstract][Full Text] [Related]
50. Regulation of dendritic cell function by NK cells: mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation.
Pan PY; Gu P; Li Q; Xu D; Weber K; Chen SH
J Immunol; 2004 Apr; 172(8):4779-89. PubMed ID: 15067054
[TBL] [Abstract][Full Text] [Related]
51. Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide.
Togashi Y; Chamoto K; Wakita D; Tsutsumi N; Iwakura Y; Matsubara N; Kitamura H; Nishimura T
Cancer Sci; 2007 May; 98(5):721-5. PubMed ID: 17359285
[TBL] [Abstract][Full Text] [Related]
52. Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells.
Jewett A; Bonavida B
J Clin Immunol; 1995 Jan; 15(1):35-44. PubMed ID: 7759599
[TBL] [Abstract][Full Text] [Related]
53. Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells.
Nakui M; Ohta A; Sekimoto M; Sato M; Iwakabe K; Yahata T; Kitamura H; Koda T; Kawano T; Makuuchi H; Taniguchi M; Nishimura T
Clin Exp Metastasis; 2000; 18(2):147-53. PubMed ID: 11235990
[TBL] [Abstract][Full Text] [Related]
54. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells.
Eberl G; MacDonald HR
Eur J Immunol; 2000 Apr; 30(4):985-92. PubMed ID: 10760785
[TBL] [Abstract][Full Text] [Related]
55. The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells.
Liu S; Yu Y; Zhang M; Wang W; Cao X
J Immunol; 2001 May; 166(9):5407-15. PubMed ID: 11313377
[TBL] [Abstract][Full Text] [Related]
56. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
57. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation.
Matsuda H; Suda T; Sato J; Nagata T; Koide Y; Chida K; Nakamura H
Am J Respir Cell Mol Biol; 2005 Jul; 33(1):22-31. PubMed ID: 15802553
[TBL] [Abstract][Full Text] [Related]
58. [Activation of natural killer T cells by NK-4, a criptocyanine dye].
Kunikata T; Kohno K; Ushio S; Fukuda S
Yakugaku Zasshi; 2011; 131(11):1667-74. PubMed ID: 22041707
[TBL] [Abstract][Full Text] [Related]
59. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
[TBL] [Abstract][Full Text] [Related]
60. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.
Glässner A; Eisenhardt M; Krämer B; Körner C; Coenen M; Sauerbruch T; Spengler U; Nattermann J
Lab Invest; 2012 Jul; 92(7):967-77. PubMed ID: 22449797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
